I think we will be dry on news until EU meeting. Then I would think patent news towards end of year. I say that because in the PRs it sounds like around phase 1 is when they will be looking to "possibly" uplist. That will take a drive up in price/followed by a reverse split to get price needed for requirements. Got a 12-14 months probably before phase 1 is finished. Just my thoughts.
(0)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links